1. Bain JN, Prendergast MA, Terry AV, Arneric SP, Smith MA, Buccafusco JJ (2003) Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. Psychopharmacology 169:150–160
2. Blough DS (1959) Delayed matching in the pigeon. J Exp Anal Behav 2:151–160
3. Broadbear JH, Sumpter TL, Burke TF, Husbands SM, Lewis JW, Woods JH, Traynor JR (2000) Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinoniception in the mouse: comparison with clocinnamox, β-funaltrexamine, and β-chlornaltrexamine. J Pharmacol Exp Ther 294:933–940
4. Carpenter M, Berry H, Pelletier AL (2019) Clinically relevant drug-drug interactions in primary care. Am Fam Physician 99:558–564
5. Chamberlain SR, Mogg K, Bradley BP, Koch A, Dodds CM, Tao WX, Maltby K, Sarai B, Napolitano A, Richards DB, Bullmore ET, Nathan PJ (2012) Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals. Psychopharmacology 224:501–509